• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.

作者信息

Metcalfe John Z, Vittinghoff Eric, Hopewell Philip C

机构信息

Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital.

Department of Epidemiology and Biostatistics, University of California, San Francisco.

出版信息

Clin Infect Dis. 2015 Mar 15;60(6):970. doi: 10.1093/cid/ciu1147. Epub 2014 Dec 19.

DOI:10.1093/cid/ciu1147
PMID:25527651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6276940/
Abstract
摘要

相似文献

1
Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.绿灯委员会实施情况及二线耐药性获得情况分析
Clin Infect Dis. 2015 Mar 15;60(6):970. doi: 10.1093/cid/ciu1147. Epub 2014 Dec 19.
2
[Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis].[耐多药结核病治疗期间获得的广泛耐药性]
Med Mal Infect. 2015 Jan-Feb;45(1-2):61-2. doi: 10.1016/j.medmal.2014.10.010.
3
Acquired drug resistance: we can do more than we think!获得性耐药：我们能做到的比想象中更多！
Clin Infect Dis. 2015 Mar 15;60(6):969-70. doi: 10.1093/cid/ciu1146. Epub 2014 Dec 19.
4
Acquired drug resistance during inadequate therapy in a young child with tuberculosis.一名患结核病幼儿在治疗不充分期间出现获得性耐药。
Pediatr Infect Dis J. 2014 Aug;33(8):883-5. doi: 10.1097/INF.0000000000000336.
5
The surprising diversity of Mycobacterium tuberculosis: change you can believe in.结核分枝杆菌惊人的多样性：你可以相信的变化。
J Infect Dis. 2012 Dec 1;206(11):1642-4. doi: 10.1093/infdis/jis603. Epub 2012 Sep 14.
6
Bedaquiline.贝达喹啉
Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2.
7
[Reasons for drug-resistant tuberculosis emergence].[耐多药结核病出现的原因]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5.
8
[The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].[考虑到结核病病原体的新数据，结核病化疗中的问题]
Antibiot Khimioter. 2000;45(5):3-5.
9
Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.布基纳法索新发病例和复治肺结核病例中的抗结核药物耐药性。
Int J Tuberc Lung Dis. 2010 Nov;14(11):1424-9.
10
[Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].[肺结核患者对经典药物原发性耐药的一些流行病学和临床方面]
Tuberkuloza. 1966 Jan-Jun;18(1-3):300-6.

引用本文的文献

1
Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.对索曼等人、阿尔夫费纳尔等人、梅特卡夫等人以及拉乌尔的回复。
Clin Infect Dis. 2015 Mar 15;60(6):971-3. doi: 10.1093/cid/ciu1150. Epub 2014 Dec 19.

本文引用的文献

1
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.针对500多名连续患者的耐多药结核病的成功“孟加拉国9个月治疗方案” 。
Int J Tuberc Lung Dis. 2014 Oct;18(10):1180-7. doi: 10.5588/ijtld.14.0100.
2
Propensity-matching analysis is not straightforward.倾向匹配分析并不简单。
Am J Respir Crit Care Med. 2014 Aug 15;190(4):362-3. doi: 10.1164/rccm.201406-0996ED.
3
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.耐多药结核病治疗期间获得的广泛耐药
Clin Infect Dis. 2014 Oct 15;59(8):1049-63. doi: 10.1093/cid/ciu572. Epub 2014 Jul 23.
4
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.左氧氟沙星与莫西沙星治疗耐多药结核病的比较。
Am J Respir Crit Care Med. 2013 Oct 1;188(7):858-64. doi: 10.1164/rccm.201303-0604OC.
5
Delamanid for multidrug-resistant pulmonary tuberculosis.德拉马尼治疗耐多药肺结核。
N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433.
6
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.印度泰米尔纳德邦耐多药结核病患者标准化治疗的结果。
Indian J Med Res. 2011 May;133(5):529-34.
7
Constructing inverse probability weights for marginal structural models.构建边际结构模型的逆概率权重。
Am J Epidemiol. 2008 Sep 15;168(6):656-64. doi: 10.1093/aje/kwn164. Epub 2008 Aug 5.
8
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.耐多药结核病痰培养转阴时间：预测因素及其与治疗结果的关系
Ann Intern Med. 2006 May 2;144(9):650-9. doi: 10.7326/0003-4819-144-9-200605020-00008.
9
Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.扩大艾滋病毒/艾滋病治疗规模：从耐多药结核病中吸取的经验教训。
Lancet. 2004 Jan 24;363(9405):320-4. doi: 10.1016/S0140-6736(03)15394-9.
10
From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift.从耐多药结核病到扩大直接督导下的短程化疗及未来：充分利用范式转变
Tuberculosis (Edinb). 2003;83(1-3):59-65. doi: 10.1016/s1472-9792(02)00078-1.